Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
26
2015
State Pharmaceutical Pricing Disclosure Laws: Old Story, New Refrain Mintz
Aug
26
2015
AmerisourceBergen Guest Post: Solutions to Overcome Reimbursement Challenges in Personalized Medicine Foley & Lardner LLP
Aug
26
2015
Litigation Fallout From All This Supply Chain Transparency Legislation (Or, These Things Have Teeth!) (Or, The Cycle of Misfortune) Squire Patton Boggs (US) LLP
Aug
25
2015
FDA Flunks Mylan’s India Facilities, Finds cGMP Violations Mahany Law
Aug
25
2015
PTAB Denies Institution Of Kyle Bass's Ampyra Patent Challenge Foley & Lardner LLP
Aug
24
2015
Protecting Diagnostic Innovation – Two Actor Infringement Liability Foley & Lardner LLP
Aug
21
2015
New Guide On Safety Assessments of NIAS in Food-Contact Materials Available from ILSI Europe Keller and Heckman LLP
Aug
21
2015
Off-Label Marketing and False Claims Act Mintz
Aug
21
2015
FDA Adds Three New Substances to Its Inventory of Effective FCS Notifications Keller and Heckman LLP
Aug
21
2015
Food Court Report: Consumer Claims Targeting Trans Fat In Instant Noodles Case Survive Motion To Dismiss Keller and Heckman LLP
Aug
20
2015
Italian Medicines Agency Makes Public Assessment Reports Available on its Website Covington & Burling LLP
Aug
20
2015
Federal Circuit Expands Direct Divided Infringement Foley & Lardner LLP
Aug
19
2015
Amarin Ruling Solidifies Off-Label Marketing Options but Raises Questions About False Claims Act Enforcement Action McDermott Will & Emery
Aug
18
2015
The Future of Pharmaceutical Supply Chains (Or, Unpacking the Drug Quality and Security Act) Squire Patton Boggs (US) LLP
Aug
18
2015
Sequenom Seeks Rehearing En Banc Foley & Lardner LLP
Aug
17
2015
First Amendment Protects Truthful Off-Label Speech by Drug Manufacturers Mintz
Aug
17
2015
Amgen v. Apotex – what is the outcome when biosimilar applicants actually dance? Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aug
16
2015
Claims Unpatentable for Obviousness in Final Written Decision IPR2014-00402 - Butamax Advanced Biofuels v. Gevo Faegre Drinker
Aug
14
2015
U.S. v. Bayer Is Proof ─ Daubert Is Not Hard To Digest IMS Legal Strategies
Aug
13
2015
Telehealth / Remote Care 2.0: The Coming Disruption Epstein Becker & Green, P.C.
Aug
13
2015
New York Federal Court Authorizes Pharmaceutical Firm to Engage in Off-label Promotion Using Certain Specific Information and Statements Alert Barnes & Thornburg LLP
Aug
13
2015
This Week’s Health Care Update: Big Changes (Possibly) Ahead for Drug Manufacturers Mintz
Aug
13
2015
Value Of Prophetic Examples re: Lumigan Patent Claims Foley & Lardner LLP
Aug
12
2015
FDA Cites Drug Company for Kim Kardashian Endorsement Mintz
Aug
12
2015
OHIM: DETOX Is Not Descriptive For The Characteristics Of “Beers” Squire Patton Boggs (US) LLP
Aug
11
2015
Medtronic Covidien Settles More than 11,000 Claims Stark & Stark
Aug
11
2015
Lumigan Patents Upheld By Unexpected Results Foley & Lardner LLP
Aug
10
2015
Practical Implications from Amarin Morgan, Lewis & Bockius LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins